NCT06330350

Brief Summary

The goal of this observational study is to understand the perspectives and needs of patients with genodermatoses and their partners who wish to have children, regarding their decision-making process and their consideration of reproductive options. Additionally, the investigators aim to investigate the level of knowledge and perspectives of healthcare professionals (such as clinical geneticists, dermatologists and other clinicians involved), and want to explore to what extent patients and their partners are well informed about these reproductive options. To achieve this, the investigators will conduct individual semi-structured qualitative interviews with participants affected by genodermatoses (and their partners) and with healthcare professionals.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 26, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 18, 2025

Status Verified

May 1, 2025

Enrollment Period

1.7 years

First QC Date

March 11, 2024

Last Update Submit

May 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of perspectives of affected patients + partners and of healthcare professionals concerning reproductive decision-making

    Qualitative evaluation of the perspectives and needs of patients with genodermatoses and their partners who wish to have children, as well as clinicians involved in the decision-making process and the consideration of reproductive options, such as prenatal diagnosis (PND), pre-implantation genetic testing (PGT), adoption, the use of donor gametes, refraining from having children, natural pregnancy without genetic testing or foster care. And assessing their level of knowledge on these reproductive options.

    1 day

Study Arms (6)

Keratinisation disorders

Keratinisation disorders comprise a heterogeneous group characterised by abnormal epidermal differentiation, such as variants of ichthyosis and palmoplantar keratoderma.

Other: Qualitative interview

Skin fragility disorders

Skin fragility disorders comprise a group of inherited blistering diseases, such as variants of epidermolysis bullosa.

Other: Qualitative interview

Ectodermal dysplasias

Ectodermal dysplasias consists of multiple inherited disorders that are characterised by abnormalities of the embryonic ectoderm, such as hair, nails, sweat glands or teeth.

Other: Qualitative interview

Dermato-oncogenetic syndromes

This group are genodermatoses associated with the development of malignancies ((non-)cutaneous), such as basal cell nevus syndrome (BCNS), Birt-Hoog-Dubé syndrome, tuberous sclerosis, etc.

Other: Qualitative interview

Other genodermatoses

In this group genodermatoses are listed that do not fit the other groups as mentioned above, for example albinism and cutis laxa.

Other: Qualitative interview

Health care professionals

This group includes clinical geneticists, dermatologists and other clinicians involved in the care of patients with genodermatoses.

Other: Qualitative interview

Interventions

Gaining insight into the perspectives of patients with genodermatoses and their partners, and health care professionals concerning reproductive decision-making and counselling.

Dermato-oncogenetic syndromesEctodermal dysplasiasHealth care professionalsKeratinisation disordersOther genodermatosesSkin fragility disorders

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult patients with genodermatosis (i.e, keratinisation disorders, skin fragility diseases, ectodermal dysplasias, dermato-oncological syndromes, other genodermatoses) and a desire to have children, with if applicable his or her partner with a desire to have children, and health care professionals involved with the care of genodermatology patients (e.g. clinical geneticists, dermatologists).

You may qualify if:

  • Adult patients with genodermatosis (i.e, keratinisation disorders, skin fragility diseases, ectodermal dysplasias, dermato-oncological syndromes, other genodermatoses) and a desire to have children, with if applicable his or her partner with a desire to have children
  • Patients with clinically and molecularly confirmed variant of a genodermatosis
  • Health care professionals involved with the care of genodermatology patients (e.g. clinical geneticists, dermatologists)

You may not qualify if:

  • Not being able to communicate verbally in Dutch or English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University Medical Center

Maastricht, Limburg, 6202 AZ, Netherlands

RECRUITING

MeSH Terms

Conditions

IchthyosisKeratoderma, PalmoplantarEpidermolysis BullosaEctodermal DysplasiaBasal Cell Nevus SyndromeBirt-Hogg-Dube SyndromeTuberous SclerosisCutis LaxaAlbinism

Condition Hierarchy (Ancestors)

Skin AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesKeratosisSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, GeneticGenetic Diseases, InbornSkin Diseases, VesiculobullousAbnormalities, MultipleOdontogenic CystsJaw CystsBone CystsCystsNeoplasmsCarcinoma, Basal CellCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasms, Basal CellNeoplastic Syndromes, HereditaryBone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesJaw DiseasesStomatognathic DiseasesHamartomaNeoplasms, Multiple PrimaryMalformations of Cortical Development, Group IMalformations of Cortical DevelopmentNervous System MalformationsNervous System DiseasesNeurocutaneous SyndromesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesConnective Tissue DiseasesEye Diseases, HereditaryEye DiseasesAmino Acid Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsHypopigmentationPigmentation DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Antoni Gostynski, MD, PhD

    Maastricht University Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fauve C van Veen, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2024

First Posted

March 26, 2024

Study Start

January 1, 2024

Primary Completion

August 31, 2025

Study Completion

December 31, 2025

Last Updated

May 18, 2025

Record last verified: 2025-05

Locations